SMPD3‐ALK: A novel ALK fusion gene in lung adenocarcinoma
Gespeichert in:
| Veröffentlicht in: | Clinical genetics 2021-03, Vol.99 (3), p.488-489 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 489 |
|---|---|
| container_issue | 3 |
| container_start_page | 488 |
| container_title | Clinical genetics |
| container_volume | 99 |
| creator | Liang, Yuepei Wang, Yang Wang, Wenjing Zhao, Juan Xu, Mian Zheng, Min |
| description | |
| doi_str_mv | 10.1111/cge.13891 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7898813</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2487160011</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4101-414a45974aeea86dc51391bfe48d97539b26c27f6145012a65fe636c61792d43</originalsourceid><addsrcrecordid>eNp1kNFKwzAUhoMobk4vfAEpeOVFt5wmTRsFYcw5xYmCuw9ZmtaOLpntOtmdj-Az-iRGO4demJvD4Xx8-fkROgbcBfd6KtNdIDGHHdQGwrmPMaa7qO0G9zkw0kIHVTVzK4lCvo9ahIQhA07b6OLp_vGKfLy998d3517fM3alC88tXlpXuTVepo32cuMVtck8mWhjlSxVbuxcHqK9VBaVPtrMDppcDyeDG3_8MLod9Me-ooDBp0AlDXlEpdYyZokKXUaYpprGCY9CwqcBU0GUMqAhhkCyMNWMMMUg4kFCSQddNtpFPZ3rRGmzLGUhFmU-l-VaWJmLvxeTP4vMrkQU8zgG4gSnG0FpX2pdLcXM1qVxkUVA4wgYxgCOOmsoVdqqKnW6_QGw-KpZuJrFd82OPfkdaUv-9OqAXgO85oVe_28Sg9GwUX4C9faE3w</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2487160011</pqid></control><display><type>article</type><title>SMPD3‐ALK: A novel ALK fusion gene in lung adenocarcinoma</title><source>Wiley Online Library - AutoHoldings Journals</source><source>MEDLINE</source><creator>Liang, Yuepei ; Wang, Yang ; Wang, Wenjing ; Zhao, Juan ; Xu, Mian ; Zheng, Min</creator><creatorcontrib>Liang, Yuepei ; Wang, Yang ; Wang, Wenjing ; Zhao, Juan ; Xu, Mian ; Zheng, Min</creatorcontrib><identifier>ISSN: 0009-9163</identifier><identifier>EISSN: 1399-0004</identifier><identifier>DOI: 10.1111/cge.13891</identifier><identifier>PMID: 33556194</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Adenocarcinoma ; Adenocarcinoma of Lung - diagnosis ; Adenocarcinoma of Lung - drug therapy ; Adenocarcinoma of Lung - genetics ; Anaplastic Lymphoma Kinase - genetics ; Antineoplastic Agents - therapeutic use ; Enzyme Inhibitors - therapeutic use ; Fusion protein ; Gene Fusion ; High-Throughput Nucleotide Sequencing ; Humans ; Letter to the Editor ; Letters to the Editor ; Lung Neoplasms - diagnosis ; Lung Neoplasms - drug therapy ; Lung Neoplasms - genetics ; Male ; Middle Aged ; Sphingomyelin Phosphodiesterase - genetics</subject><ispartof>Clinical genetics, 2021-03, Vol.99 (3), p.488-489</ispartof><rights>2021 The Authors. published by John Wiley & Sons Ltd.</rights><rights>2021. This article is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4101-414a45974aeea86dc51391bfe48d97539b26c27f6145012a65fe636c61792d43</citedby><cites>FETCH-LOGICAL-c4101-414a45974aeea86dc51391bfe48d97539b26c27f6145012a65fe636c61792d43</cites><orcidid>0000-0001-7381-111X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fcge.13891$$EPDF$$P50$$Gwiley$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fcge.13891$$EHTML$$P50$$Gwiley$$Hfree_for_read</linktohtml><link.rule.ids>230,314,776,780,881,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33556194$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Liang, Yuepei</creatorcontrib><creatorcontrib>Wang, Yang</creatorcontrib><creatorcontrib>Wang, Wenjing</creatorcontrib><creatorcontrib>Zhao, Juan</creatorcontrib><creatorcontrib>Xu, Mian</creatorcontrib><creatorcontrib>Zheng, Min</creatorcontrib><title>SMPD3‐ALK: A novel ALK fusion gene in lung adenocarcinoma</title><title>Clinical genetics</title><addtitle>Clin Genet</addtitle><subject>Adenocarcinoma</subject><subject>Adenocarcinoma of Lung - diagnosis</subject><subject>Adenocarcinoma of Lung - drug therapy</subject><subject>Adenocarcinoma of Lung - genetics</subject><subject>Anaplastic Lymphoma Kinase - genetics</subject><subject>Antineoplastic Agents - therapeutic use</subject><subject>Enzyme Inhibitors - therapeutic use</subject><subject>Fusion protein</subject><subject>Gene Fusion</subject><subject>High-Throughput Nucleotide Sequencing</subject><subject>Humans</subject><subject>Letter to the Editor</subject><subject>Letters to the Editor</subject><subject>Lung Neoplasms - diagnosis</subject><subject>Lung Neoplasms - drug therapy</subject><subject>Lung Neoplasms - genetics</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Sphingomyelin Phosphodiesterase - genetics</subject><issn>0009-9163</issn><issn>1399-0004</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>EIF</sourceid><recordid>eNp1kNFKwzAUhoMobk4vfAEpeOVFt5wmTRsFYcw5xYmCuw9ZmtaOLpntOtmdj-Az-iRGO4demJvD4Xx8-fkROgbcBfd6KtNdIDGHHdQGwrmPMaa7qO0G9zkw0kIHVTVzK4lCvo9ahIQhA07b6OLp_vGKfLy998d3517fM3alC88tXlpXuTVepo32cuMVtck8mWhjlSxVbuxcHqK9VBaVPtrMDppcDyeDG3_8MLod9Me-ooDBp0AlDXlEpdYyZokKXUaYpprGCY9CwqcBU0GUMqAhhkCyMNWMMMUg4kFCSQddNtpFPZ3rRGmzLGUhFmU-l-VaWJmLvxeTP4vMrkQU8zgG4gSnG0FpX2pdLcXM1qVxkUVA4wgYxgCOOmsoVdqqKnW6_QGw-KpZuJrFd82OPfkdaUv-9OqAXgO85oVe_28Sg9GwUX4C9faE3w</recordid><startdate>202103</startdate><enddate>202103</enddate><creator>Liang, Yuepei</creator><creator>Wang, Yang</creator><creator>Wang, Wenjing</creator><creator>Zhao, Juan</creator><creator>Xu, Mian</creator><creator>Zheng, Min</creator><general>Blackwell Publishing Ltd</general><scope>24P</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>RC3</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-7381-111X</orcidid></search><sort><creationdate>202103</creationdate><title>SMPD3‐ALK: A novel ALK fusion gene in lung adenocarcinoma</title><author>Liang, Yuepei ; Wang, Yang ; Wang, Wenjing ; Zhao, Juan ; Xu, Mian ; Zheng, Min</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4101-414a45974aeea86dc51391bfe48d97539b26c27f6145012a65fe636c61792d43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Adenocarcinoma</topic><topic>Adenocarcinoma of Lung - diagnosis</topic><topic>Adenocarcinoma of Lung - drug therapy</topic><topic>Adenocarcinoma of Lung - genetics</topic><topic>Anaplastic Lymphoma Kinase - genetics</topic><topic>Antineoplastic Agents - therapeutic use</topic><topic>Enzyme Inhibitors - therapeutic use</topic><topic>Fusion protein</topic><topic>Gene Fusion</topic><topic>High-Throughput Nucleotide Sequencing</topic><topic>Humans</topic><topic>Letter to the Editor</topic><topic>Letters to the Editor</topic><topic>Lung Neoplasms - diagnosis</topic><topic>Lung Neoplasms - drug therapy</topic><topic>Lung Neoplasms - genetics</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Sphingomyelin Phosphodiesterase - genetics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Liang, Yuepei</creatorcontrib><creatorcontrib>Wang, Yang</creatorcontrib><creatorcontrib>Wang, Wenjing</creatorcontrib><creatorcontrib>Zhao, Juan</creatorcontrib><creatorcontrib>Xu, Mian</creatorcontrib><creatorcontrib>Zheng, Min</creatorcontrib><collection>Wiley-Blackwell Open Access Collection</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Clinical genetics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Liang, Yuepei</au><au>Wang, Yang</au><au>Wang, Wenjing</au><au>Zhao, Juan</au><au>Xu, Mian</au><au>Zheng, Min</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>SMPD3‐ALK: A novel ALK fusion gene in lung adenocarcinoma</atitle><jtitle>Clinical genetics</jtitle><addtitle>Clin Genet</addtitle><date>2021-03</date><risdate>2021</risdate><volume>99</volume><issue>3</issue><spage>488</spage><epage>489</epage><pages>488-489</pages><issn>0009-9163</issn><eissn>1399-0004</eissn><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>33556194</pmid><doi>10.1111/cge.13891</doi><tpages>2</tpages><orcidid>https://orcid.org/0000-0001-7381-111X</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0009-9163 |
| ispartof | Clinical genetics, 2021-03, Vol.99 (3), p.488-489 |
| issn | 0009-9163 1399-0004 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7898813 |
| source | Wiley Online Library - AutoHoldings Journals; MEDLINE |
| subjects | Adenocarcinoma Adenocarcinoma of Lung - diagnosis Adenocarcinoma of Lung - drug therapy Adenocarcinoma of Lung - genetics Anaplastic Lymphoma Kinase - genetics Antineoplastic Agents - therapeutic use Enzyme Inhibitors - therapeutic use Fusion protein Gene Fusion High-Throughput Nucleotide Sequencing Humans Letter to the Editor Letters to the Editor Lung Neoplasms - diagnosis Lung Neoplasms - drug therapy Lung Neoplasms - genetics Male Middle Aged Sphingomyelin Phosphodiesterase - genetics |
| title | SMPD3‐ALK: A novel ALK fusion gene in lung adenocarcinoma |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T18%3A00%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=SMPD3%E2%80%90ALK:%20A%20novel%20ALK%20fusion%20gene%20in%20lung%20adenocarcinoma&rft.jtitle=Clinical%20genetics&rft.au=Liang,%20Yuepei&rft.date=2021-03&rft.volume=99&rft.issue=3&rft.spage=488&rft.epage=489&rft.pages=488-489&rft.issn=0009-9163&rft.eissn=1399-0004&rft_id=info:doi/10.1111/cge.13891&rft_dat=%3Cproquest_pubme%3E2487160011%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2487160011&rft_id=info:pmid/33556194&rfr_iscdi=true |